Hanmi Pharm Owners 2nd Generation Lim Juhyun and Lim Jonghoon Promoted to President... "All Three Children Are Presidents"

From the left in the photo: Lim Juhyun, President of Hanmi Pharm; Lim Jonghoon, President of Hanmi Pharm; Park Junseok, Vice President of Hanmi Healthcare; Woo Kisuk, Vice President of Online Pharm.

[Asia Economy Reporter Seo So-jung] The three children of the late Lim Seong-gi, founder of Hanmi Pharmaceutical Group, have all been appointed as presidents of Hanmi Pharmaceutical.

Hanmi Pharmaceutical Group announced on the 20th the executive promotion for 2021, stating that siblings Lim Ju-hyun and Lim Jong-hoon have been appointed as presidents of Hanmi Pharmaceutical.

Newly appointed President Lim Ju-hyun was in charge of global strategy and human resource development (HRD). Newly appointed President Lim Jong-hoon has been responsible for business planning and chief investment officer (CIO) duties, and concurrently serves as CEO of Hanmi Healthcare.

Thus, following the eldest of the three children (two sons and one daughter) of Chairman Lim Seong-gi, Lim Jong-yoon, president of Hanmi Pharmaceutical, the siblings Lim Ju-hyun and Lim Jong-hoon have all been appointed as presidents.

Lim Jong-yoon, president of Hanmi Pharmaceutical, also concurrently serves as CEO and president of the holding company Hanmi Science.

Currently, Hanmi Pharmaceutical is led by professional managers Woo Jong-su and Kwon Se-chang as co-CEOs.

An industry insider said, "With all three siblings of the late Chairman Lim taking the forefront of management, competition among the second generation will also be fully underway."

This content was produced with the assistance of AI translation services.